Showing results (131-140 of 151) with videos related to
Sort By:
Pageof 16
Diabetes Care|March 14, 2012
Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial infarctionJoshua M Stolker, John A Spertus, Darren K McGuire, et al.BMJ Open|July 9, 2023
Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Cerner Real-World Data™Erin M Tallon, Mary Pat Gallagher, Vincent S Staggs, et al.Diabetes, Obesity & Metabolism|November 4, 2020
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studiesMoshe Phillip, Chantal Mathieu, Marcus Lind, et al.Diabetologia|April 26, 2024
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trialsSofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, et al.Circulation. Cardiovascular Quality and Outcomes|April 23, 2015
Recognition of incident diabetes mellitus during an acute myocardial infarctionSuzanne V Arnold, Joshua M Stolker, Kasia J Lipska, et al.JMIR Diabetes|May 24, 2023
An "All-Data-on-Hand" Deep Learning Model to Predict Hospitalization for Diabetic Ketoacidosis in Youth With Type 1 Diabetes: Development and Validation StudyDavid D Williams, Diana Ferro, Colin Mullaney, et al.American Heart Journal|December 5, 2016
Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapyAnna Grodzinsky, Suzanne V Arnold, Tracy Y Wang, et al.Diabetic Medicine : a Journal of the British Diabetic Association|October 2, 2025
A cohort description and comparison of four European national diabetes registries for the REDDIE projectJonah J C Thomas, Stefanie Lanzinger, Kathrine Kold Soerensen, et al.JMIR Diabetes|September 25, 2025
Toward a Clinically Actionable, Electronic Health Record-Based Machine Learning Model to Forecast 90-Day Change in Hemoglobin A1c in Youth With Type 1 Diabetes: Feasibility and Model Development StudyErin M Tallon, David D Williams, Cintya Schweisberger, et al.Diabetes, Obesity & Metabolism|February 25, 2026
Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetesKathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini, et al.Pageof 16